PARP Inhibitors: Extending Benefit Beyond BRCA Mutant Cancers
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-0968
Full Text
Open PDFAbstract
Available in full text
Date
February 13, 2019
Authors
Publisher
American Association for Cancer Research (AACR)